Ada Bertoli
Impact in
- Virology top 2%
- HIV Research and Treatment
- Infectious Diseases top 1%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- HIV/AIDS drug development and treatment 60
- HIV/AIDS Research and Interventions 6
- SARS-CoV-2 and COVID-19 Research 2
- COVID-19 Clinical Research Studies 1
- Virology 26
- HIV Research and Treatment 26
- Co-authors
- Carlo Federico Perno (53 shared papers)Andrea Antinori (27 shared papers)Francesca Ceccherini‐Silberstein (32 shared papers)Federica Forbici (26 shared papers)Antonella d’Arminio Monforte (9 shared papers)Valentina Svicher (20 shared papers)Maria Mercedes Santoro (24 shared papers)Claudia Balotta (6 shared papers)
In The Last Decade
Ada Bertoli
117 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 58
- Virology 481
- Infectious Diseases 1.3k
- Hepatology 328
- Epidemiology 339
- Emergency Medicine 23
Countries citing papers authored by Ada Bertoli
This map shows the geographic impact of Ada Bertoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ada Bertoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ada Bertoli more than expected).
Fields of papers citing papers by Ada Bertoli
This network shows the impact of papers produced by Ada Bertoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ada Bertoli. The network helps show where Ada Bertoli may publish in the future.
Co-authors
The 25 scholars most cited alongside Ada Bertoli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 119 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 105 | |
| 2 | 2004 | 103 | |
| 3 | 2003 | 90 | |
| 4 | 2011 | 80 | |
| 5 | 2017 | 79 | |
| 6 | 2012 | 78 | |
| 7 | 2014 | 76 | |
| 8 | 2001 | 72 | |
| 9 | 2006 | 65 | |
| 10 | 2004 | 62 | |
| 11 | 2007 | 57 | |
| 12 | 2005 | 49 | |
| 13 | 2006 | 46 | |
| 14 | 2002 | 42 | |
| 15 | 2011 | 41 | |
| 16 | Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group. | 2010 | 40 |
| 17 | 2002 | 39 | |
| 18 | 2018 | 38 | |
| 19 | Clinical implications of HIV dynamics and drug resistance in macrophages. | 1998 | 36 |
| 20 | 2016 | 34 |
About Ada Bertoli
Ada Bertoli is a scholar working on Infectious Diseases, Virology, Hepatology, Epidemiology and Clinical Biochemistry, having authored 119 papers that have together received 2.3k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (60 papers), HIV Research and Treatment (26 papers), Hepatitis B Virus Studies (26 papers), Hepatitis C virus research (15 papers), HIV/AIDS Research and Interventions (6 papers), SARS-CoV-2 and COVID-19 Research (2 papers), HIV-related health complications and treatments (1 paper) and COVID-19 Clinical Research Studies (1 paper). The work is most often cited by research in Virology (481 citations), Infectious Diseases (1.3k citations), Hepatology (328 citations), Epidemiology (339 citations) and Emergency Medicine (23 citations). Ada Bertoli has collaborated with scholars based in Italy, France and Germany. Frequent co-authors include Carlo Federico Perno, Andrea Antinori, Francesca Ceccherini‐Silberstein, Federica Forbici, Antonella d’Arminio Monforte, Valentina Svicher, Maria Mercedes Santoro, Claudia Balotta, Caterina Gori and Massimo Andreoni. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Journal of Hepatology, Digestive and Liver Disease, Journal of Clinical Virology and AIDS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.